Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: Implications for molecular targeted therapy

Naoshi Nishina, Jun Kikuchi, Misato Hashizume, Keiko Yoshimoto, Hideto Kameda, Tsutomu Takeuchi

Research output: Contribution to journalLetter

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)945-947
Number of pages3
JournalAnnals of the rheumatic diseases
Volume73
Issue number5
DOIs
Publication statusPublished - 2014 May

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this